Insider · CIK 0001406836

Schobel Alexander Mark

Reports to the SEC for 1 company · WARREN, NJ

sec.gov

Transactions

Companies

Filings

CIK

0001406836

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2024-03-15	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−50K sh	$6.00	−$300K	984,476
2024-03-09	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−9,645 sh	$4.88	−$47.1K	980,726
2024-03-09	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−5,895 sh	$4.88	−$28.8K	1,034,476
2024-03-08	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−25K sh	$5.19	−$130K	1,040,371
2024-03-07	AQSTAquestive Therapeutics, Inc.A Award	Chief Innovation/Tech Officer	AAward	+82.5K sh	—	—	1,065,371
2024-03-07	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Innovation/Tech Officer	AAward	+41.3K sh	—	—	41,250
2023-08-09	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Innovation/Tech Officer	AAward	+50K sh	—	—	50,000
2023-05-05	AQSTAquestive Therapeutics, Inc. · Performance Stock UnitsA Award	Chief Innovation/Tech Officer	AAward	+50K sh	—	—	50,000
2023-03-09	AQSTAquestive Therapeutics, Inc.A Award	Chief Innovation/Tech Officer	AAward	+100K sh	—	—	982,871
2022-11-04	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Innovation/Tech Officer	AAward	+40K sh	—	—	40,000
2022-06-08	AQSTAquestive Therapeutics, Inc.P Purchase	Chief Innovation/Tech Officer	PPurchase	+45.9K sh	$0.96	+$44K	882,871
2022-06-08	AQSTAquestive Therapeutics, Inc. · Warrant (Right to Buy)P Purchase	Chief Innovation/Tech Officer	PPurchase	+45.9K sh	$0.13	+$5,963.23	45,871
2022-03-10	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Innovation/Tech Officer	AAward	+75K sh	—	—	75,000
2021-03-11	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Innovation/Tech Officer	AAward	+70K sh	—	—	70,000
2021-02-10	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−23.5K sh	$6.75	−$158K	837,000
2021-02-09	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−11.5K sh	$6.75	−$77.9K	860,460
2021-02-08	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−40.8K sh	$6.50	−$265K	872,000
2020-06-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+333 sh	—	—	912,886
2020-06-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−94 sh	$4.86	−$456.84	912,792
2020-06-30	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−333 sh	—	—	0
2020-05-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+14.6K sh	—	—	916,685
2020-05-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−4,132 sh	$4.87	−$20.1K	912,553
2020-05-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−14.6K sh	—	—	0
2020-05-08	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−40K sh	$5.00	−$200K	902,113
2020-04-29	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−40K sh	$4.50	−$180K	1,022,113
2020-04-27	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−40K sh	$4.00	−$160K	942,113
2020-04-14	AQSTAquestive Therapeutics, Inc.S Sale	Chief Innovation/Tech Officer	SSale	−40K sh	$3.70	−$148K	982,113
2020-03-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+329 sh	—	—	1,062,210
2020-03-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−97 sh	$2.19	−$212.43	1,062,113
2020-03-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−329 sh	—	—	333
2020-03-16	AQSTAquestive Therapeutics, Inc. · Non-Qualified Stock Option (right to buy)A Award	Chief Innovation/Tech Officer	AAward	+70K sh	—	—	70,000
2020-02-29	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+14.6K sh	—	—	1,066,947
2020-02-29	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−5,066 sh	$3.73	−$18.9K	1,061,881
2020-02-29	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−14.6K sh	—	—	14,572
2019-12-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+329 sh	—	—	1,044,494
2019-12-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−329 sh	$5.82	−$1,914.78	1,044,165
2019-12-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−329 sh	—	—	662
2019-12-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−147 sh	$5.82	−$855.54	1,052,375
2019-11-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−6,544 sh	$7.79	−$51K	1,052,193
2019-11-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+14.6K sh	—	—	1,058,737
2019-11-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−14.6K sh	$7.79	−$114K	1,044,165
2019-11-30	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−14.6K sh	—	—	29,144
2019-09-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+329 sh	—	—	1,044,310
2019-09-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−145 sh	$3.18	−$461.1	1,044,165
2019-09-30	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−329 sh	—	—	991
2019-08-31	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+14.6K sh	—	—	1,050,441
2019-08-31	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−6,460 sh	$3.80	−$24.5K	1,043,981
2019-08-31	AQSTAquestive Therapeutics, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	−14.6K sh	—	—	43,716
2019-06-30	AQSTAquestive Therapeutics, Inc.M Exercise/Conversion	Chief Innovation/Tech Officer	MExercise/Conversion	+329 sh	—	—	1,036,018
2019-06-30	AQSTAquestive Therapeutics, Inc.F Tax Payment	Chief Innovation/Tech Officer	FTax Payment	−149 sh	$4.20	−$625.8	1,035,869

Recent filings

Accepted (ET)
Oct 24/A
Schobel Alexander Mark0001214659-24-017011
SEC(opens sec.gov)
Mar 194
Schobel Alexander Mark0001214659-24-004795
SEC(opens sec.gov)
Mar 124
Schobel Alexander Mark0001214659-24-004389
SEC(opens sec.gov)
Mar 114
Schobel Alexander Mark0001214659-24-004307
SEC(opens sec.gov)
Aug 94
Schobel Alexander Mark0001214659-23-010922
SEC(opens sec.gov)
May 54
Schobel Alexander Mark0001214659-23-006558
SEC(opens sec.gov)
Mar 94
Schobel Alexander Mark0001214659-23-003692
SEC(opens sec.gov)
Nov 84
Schobel Alexander Mark0001214659-22-013279
SEC(opens sec.gov)
Jun 104
Schobel Alexander Mark0001628280-22-016875
SEC(opens sec.gov)
Mar 144
Schobel Alexander Mark0001214659-22-003898
SEC(opens sec.gov)
Mar 154
Schobel Alexander Mark0001214659-21-003148
SEC(opens sec.gov)
Feb 104
Schobel Alexander Mark0001214659-21-001520
SEC(opens sec.gov)
Feb 94
Schobel Alexander Mark0001214659-21-001480
SEC(opens sec.gov)
Jul 24
Schobel Alexander Mark0001214659-20-006105
SEC(opens sec.gov)

Companies

Aquestive Therapeutics, Inc.Chief Innovation/Tech OfficerAQST

Address

C/O AQUESTIVE THERAPEUTICS, INC. 30 TECHNOLOGY DRIVE

WARREN, NJ, 07059